Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis

Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system and mainly affects young adults. Its natural history has changed in recent years with the advent of disease-modifying drugs, which have been available since the early 1990s. The increasing number of first-line a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lugaresi, Alessandra, di Ioia, Maria, Travaglini, Daniela, Pietrolongo, Erika, Pucci, Eugenio, Onofrj, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699254/
https://www.ncbi.nlm.nih.gov/pubmed/23836975
http://dx.doi.org/10.2147/NDT.S45144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699254/
https://www.ncbi.nlm.nih.gov/pubmed/23836975
http://dx.doi.org/10.2147/NDT.S45144

Ejemplares similares